These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2234284)

  • 1. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease.
    Goudsmit E; Hofman MA; Fliers E; Swaab DF
    Neurobiol Aging; 1990; 11(5):529-36. PubMed ID: 2234284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease.
    Van der Woude PF; Goudsmit E; Wierda M; Purba JS; Hofman MA; Bogte H; Swaab DF
    Neurobiol Aging; 1995; 16(1):11-8. PubMed ID: 7723930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unchanged amounts of vasopressin mRNA in the supraoptic and paraventricular nucleus during aging and in Alzheimer's disease.
    Lucassen PJ; Van Heerikhuize JJ; Guldenaar SE; Pool CW; Hofman MA; Swaab DF
    J Neuroendocrinol; 1997 Apr; 9(4):297-305. PubMed ID: 9147293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal hypertrophy in the human supraoptic and paraventricular nucleus in aging and Alzheimer's disease.
    Vogels OJ; Broere CA; Nieuwenhuys R
    Neurosci Lett; 1990 Feb; 109(1-2):62-7. PubMed ID: 2314642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphometric analysis of the supraoptic nucleus in the human brain.
    Hofman MA; Goudsmit E; Purba JS; Swaab DF
    J Anat; 1990 Oct; 172():259-70. PubMed ID: 2272907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus.
    Lucassen PJ; Ravid R; Gonatas NK; Swaab DF
    Brain Res; 1993 Dec; 632(1-2):105-13. PubMed ID: 8149218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypothalamus in Alzheimer's disease: a Golgi and electron microscope study.
    Baloyannis SJ; Mavroudis I; Mitilineos D; Baloyannis IS; Costa VG
    Am J Alzheimers Dis Other Demen; 2015 Aug; 30(5):478-87. PubMed ID: 25380804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The supraoptic and paraventricular nuclei in healthy aging and neurodegeneration.
    Stewart CA; Finger EC
    Handb Clin Neurol; 2021; 180():105-123. PubMed ID: 34225924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic evaluation of the supraoptic and paraventricular nuclei in dementia.
    Diodati D; Cyn-Ang L; Kertesz A; Finger E
    Can J Neurol Sci; 2012 Mar; 39(2):213-9. PubMed ID: 22343156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus: size changes in relation to age and sex.
    Ishunina TA; Swaab DF
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4637-44. PubMed ID: 10599731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional neuroanatomy and neuropathology of the human hypothalamus.
    Swaab DF; Hofman MA; Lucassen PJ; Purba JS; Raadsheer FC; Van de Nes JA
    Anat Embryol (Berl); 1993 Apr; 187(4):317-30. PubMed ID: 8512084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin cell number in the human paraventricular nucleus remains constant with aging and in Alzheimer's disease.
    Wierda M; Goudsmit E; Van der Woude PF; Purba JS; Hofman MA; Bogte H; Swaab DF
    Neurobiol Aging; 1991; 12(5):511-6. PubMed ID: 1770986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular density of the human paraventricular nucleus decreases with aging but not hypertension.
    Abernethy WB; Bell MA; Morris M; Moody DM
    Exp Neurol; 1993 Jun; 121(2):270-4. PubMed ID: 8339778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease.
    Ishunina TA; van Beurden D; van der Meulen G; Unmehopa UA; Hol EM; Huitinga I; Swaab DF
    Neurobiol Aging; 2005 Feb; 26(2):173-94. PubMed ID: 15582747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibrillary pathology in the human paraventricular and supraoptic nuclei.
    Schultz C; Ghebremedhin E; Braak H; Braak E
    Acta Neuropathol; 1997 Jul; 94(1):99-102. PubMed ID: 9224538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Alzheimer's disease in the magnocellular neurones of the supraoptic and paraventricular nuclei of the hypothalamus and their relationship to the noradrenergic deficit.
    Mann DM; Yates PO; Marcyniuk B
    Clin Neuropathol; 1985; 4(3):127-34. PubMed ID: 3160517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to mild stress and brain derived neurotrophin factor (BDNF) immunoreactivity in the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei: Comparison between aged and adult rats.
    Badowska-Szalewska E; Ludkiewicz B; Krawczyk R; Moryś J
    J Chem Neuroanat; 2016 Dec; 78():57-64. PubMed ID: 27565677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifespan changes in the human hypothalamus.
    Hofman MA
    Exp Gerontol; 1997; 32(4-5):559-75. PubMed ID: 9315457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual differences in the expression of tyrosine hydroxylase mRNA in neurosecretory neurons of the human paraventricular and supraoptic nuclei: positive correlation with vasopressin mRNA.
    Panayotacopoulou MT; Malidelis Y; van Heerikhuize J; Unmehopa U; Swaab D
    Neuroendocrinology; 2005; 81(5):329-38. PubMed ID: 16210867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional D1 and D5 dopamine receptors are expressed in the suprachiasmatic, supraoptic, and paraventricular nuclei of primates.
    Rivkees SA; Lachowicz JE
    Synapse; 1997 May; 26(1):1-10. PubMed ID: 9097400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.